FDA REGS: THREE-QUARTERS COULD BE DELETED OR REINVENTED, FDA's HOLSTON TELLS NAPM; GENERIC INDUSTRY AND FDA PURSUING WAYS FOR GENERIC FIRMS TO JOIN ICH TALKS
Executive Summary
Three-quarters of current FDA regulations could be dropped or "reinvented," FDA Office of External Affairs Deputy Commissioner Sharon Smith Holston told the National Association of Pharmaceutical Manufacturers mid-year meeting in Washington, D.C. June 21.